Publication | Open Access
Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy
231
Citations
45
References
2007
Year
These results therefore indicate a new and important role for FXR in the kidney and provide new therapeutic avenues for the treatment of diabetic nephropathy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1